Circadian Rhythm and Metabolic Effects of Exercise
HITMet
Time of Day Specific Glycaemic and Metabolic Response to High-Intensity Interval Training
1 other identifier
interventional
48
1 country
1
Brief Summary
Physical exercise is efficacious in controlling blood glucose levels in individuals with Type 2 diabetes. An individual's exercise capacity and ability to utilize glucose as an energy source oscillates throughout the day. Hence, the beneficial effects of exercise on blood glucose levels may depend on the time of day when the exercise bout is performed. However, the time of day in which the most beneficial adaptations to exercise can be achieved remains unknown. This project aims to answer the following questions: Does time of day impact the beneficial effects of exercise on blood glucose? If so, when can the most beneficial effects of exercise be achieved? Which metabolic mechanisms links time of day, exercise and blood glucose control? To address these questions, individuals with or without Type 2 diabetes will perform an exercise session at two different times (09:00 and 16:00), and continuous glucose monitoring will be used to assess the effects of exercise on blood glucose. We will determine the specific metabolic processes which promote the most beneficial blood glucose response. To achieve this, we will measure which metabolic substrates (carbohydrates, lipids and proteins) are used and which metabolites produced in blood, skeletal muscle and adipose tissue in response to exercise at different times of the day.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus-type-2
Started Nov 2021
Typical duration for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2021
CompletedFirst Posted
Study publicly available on registry
November 10, 2021
CompletedStudy Start
First participant enrolled
November 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2024
CompletedFebruary 21, 2025
February 1, 2025
2.6 years
October 19, 2021
February 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Exercise-induced Changes in 24 Hour Interstitial Glucose Concentration
Glucose excursions will be charted using continuous interstitial glucose monitors. The day immediately before exercise will be used as baseline, the day of exercise to assess the acute response, and the day after exercise to assess lasting effects on glycemia. Exercise effects on glucose concentration will be primarily assessed by comparing 24-hour curves between conditions.
3 days (1 day before to 1 day after exercise)
Secondary Outcomes (6)
Acute Exercise-induced Changes in Interstitial Glucose Concentration
2 hours (0 minutes before to 120 minutes after exercise)
Interstitial Glucose Concentration Response to a Meal
2 days (1 day before and day of exercise)
Interstitial Glucose Concentration Variability
3 days (1 day before to 1 day after exercise)
Time Spent in Interstitial Glucose Concentration Range
3 days (1 day before to 1 day after exercise)
Nocturnal Interestitial Glucose Concentration
2 days (day of, and 1 day after exercise)
- +1 more secondary outcomes
Study Arms (2)
Morning First
EXPERIMENTALParticipants will complete a single bout of exercise at 09:00, and after at least a one-week washout perform another exercise bout at 16:00.
Afternoon First
EXPERIMENTALParticipants will complete a single bout of exercise at 16:00, and after at least a one-week washout perform another exercise bout at 09:00.
Interventions
The participants will perform a low-volume, High-intensity Intermittent Exercise bout on a cycle ergometer. Peak exercise capacity of the study participants will be determined on a separate occasion using a ramp-up maximal oxygen consumption test (VO2peak). A single exercise bout will consist of a 7-minute warm-up on a cycle ergometer, followed by 6 1-minute intervals of cycling at individual maximal capacity and 75rpm (rotations per minute). These intervals will be interspersed with 1-min breaks of cycling at low resistance and 75rpm, and the session will conclude with a 3-minute cool-down interval (20 minutes in total).
Eligibility Criteria
You may qualify if:
- Body Mass Index (BMI): 23 - 33 kg/m2
- Participants diagnosed with Type 2 Diabetes (insulin independent) or participants without Type 2 Diabetes (based on normal HbA1c and fasting glucose levels).
- Ability to provide informed consent
- Ability to complete the exercise regiment
You may not qualify if:
- Medications: Insulin
- Pre-existing cardiovascular condition (Angina pectoris, Cardiac arrhythmia, Cardiac infarction, Coronary stent / angiography, Cerebrovascular insult, Hypertension \[\> 160 mmHg systolic, or \> 95 mmHg diastolic\])
- Pre-existing blood-borne disease (HIV, Hepatitis C, MRSA)
- Pre-existing systemic or localized rheumatic illness
- Malignant Disease
- Pre-existing psychiatric disorder
- Another pre-existing systemic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Karolinska University Hospitalcollaborator
Study Sites (1)
Karolinska Institutet
Stockholm, 17177, Sweden
Related Publications (1)
Keller MJ, Brady AJ, Smith JAB, Savikj M, MacGregor K, Jollet M, Oberg SB, Nylen C, Bjornholm M, Rickenlund A, Carlsson M, Caidahl K, Krook A, Pillon NJ, Zierath JR, Wallberg-Henriksson H. Inflammatory markers and blood glucose are higher after morning vs afternoon exercise in type 2 diabetes. Diabetologia. 2025 Sep;68(9):2023-2035. doi: 10.1007/s00125-025-06477-5. Epub 2025 Jun 28.
PMID: 40580209DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Harriet Wallberg-Henriksson, MD PhD
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. MD PhD
Study Record Dates
First Submitted
October 19, 2021
First Posted
November 10, 2021
Study Start
November 10, 2021
Primary Completion
June 25, 2024
Study Completion
June 25, 2024
Last Updated
February 21, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be made available indefinetly after publication.
- Access Criteria
- Data will be available for any purpose.
Individual participant data underlying results reported in a publication will be shared after deidentification.